Effect of administration of single dose GnRH agonist in luteal phase on outcome of ICSI-ET cycles in women with previous history of IVF/ICSI failure: A randomized controlled trial

Journal of Reproduction and Infertility

Volumn 16, Issue 2, 2015, Pages 116-120

  Zafardoust, Simin ^a   Jeddi Tehrani, Mahmood ^a   Akhondi, Mohammad Mehdi ^a   Sadeghi, Mohammad Reza ^a   Kamali, Koroush ^a   Mokhtar, Sara ^a   Badehnoosh, Bita ^a   Arjmand Teymouri, Fatemeh ^a   Fatemi, Farnaz ^a   Mohammadzadeh, Afsaneh ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Decapeptil; GnRH agonist; GnRH antagonist; ICSI; Implantation failure; Intracytoplasmic sperm injection; IVF failure; Luteal phase support

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; EARLY INTERVENTION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; MEDICAL HISTORY; NIDATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

EID: 84924815210     PISSN: 22285482     EISSN: 2251676X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jindal UN, Verma S, editors. Luteal Phase Support. London-United Kingdom: Jaypee Brothers, Medical Publishers; 2013. 622 p. (Rao KA, Carp HJA, Fischer F. Textbook of In Vitro Fertilization; vol. 2).
2. Aflatoonian A, Asgharnia M, Alshohadaei FS. Comparison of progesterone administration before and after embryo transfer in ART cycles. J Reprod Infertil. 2004;5(1):44-51.
3. Smitz J, Devroey P, Camus M, Deschacht J, Khan I, Staessen C, et al. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod. 1988;3(5):585-90.
4. Van Steirteghem AC, Smitz J, Camus M, Van Waesberghe L, Deschacht J, Khan I, et al. The luteal phase after in-vitro fertilization and related procedures. Hum Reprod. 1988;3(2):161-4.
5. Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab. 2004;15(2):84-90.
6. Garcia J, Jones GS, Acosta AA, Wright GL Jr. Corpus luteum function after follicle aspiration for oocyte retrieval. Fertil Steril. 1981;36(5):565-72.
7. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod. 2002;17(9):2287-99.
8. van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2011;(10):CD009154.
9. Isik AZ, Caglar GS, Sozen E, Akarsu C, Tuncay G, Ozbicer T, et al. Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study. Reprod Biomed Online. 2009;19(4):472-7.
10. Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antago-nist-treated ovarian stimulation cycles. Hum Reprod. 2006;21(10):2572-9.
11. Oliveira JB, Baruffi R, Petersen CG, Mauri AL, Cavagna M, Franco JG Jr. Administration of sin-gle-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol. 2010;8:107.
12. Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzi TB, Devroey P, Tarlatzis BC. Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and metaanalysis. Hum Reprod Update. 2011;17(6):734-40.
13. Razieh DF, Maryam AR, Nasim T. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection. Taiwan J Obstet Gynecol. 2009;48(3):245-8.
14. Sasaki K, Norwitz ER. Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):401-8.
15. Wu S, Wilson MD, Busby ER, Isaac ER, Sherwood NM. Disruption of the single copy gonado-tropin-releasing hormone receptor in mice by gene trap: severe reduction of reproductive organs and functions in developing and adult mice. Endocrinology. 2010;151(3):1142-52.
16. Tesarik J, Greco E. The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod. 1999;14(5):1318-23.
17. Balasch J, Martinez F, Jove I, Cabre L, Coroleu B, Barri PN, et al. Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod. 1993;8(7): 1148-51.
18. Elefant E, Biour B, Blumberg-Tick J, Roux C, Thomas F. Administration of a gonadotropin-releasing hormone agonist during pregnancy: followup of 28 pregnancies exposed to triptoreline. Fertil Steril. 1995;63(5):1111-3.
19. Uehara S, Sakahira H, Tamura M, Watanabe T, Yajima A. Normal outcome following administration of gonadotropin-releasing hormone (GnRH) agonist during early pregnancy. Congenit Anom. 1998;38(1):81-5.
20. Schroder AK, Katalinic A, Diedrich K, Ludwig M. Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online. 2004;8(5):600-6.
21. Petersen CG, Mauri AL, Baruffi RL, Oliveira JB, Massaro FC, Elder K, et al. Implantation failures: success of assisted hatching with quarter-laser zona thinning. Reprod Biomed Online. 2005;10(2):224-9.